Hoofer I agree with your concerns , I'm sure the investors...

First 61 Last

Share
Profile

Follow
semi retired

8,960 Posts.

6836

11/06/14

16:07

Post #: 13511396
Share

Originally posted by hoofa ↑

Due to the fact that they have been in discussions for some time re the acquisition, one could assume that they have all but made up the mind to go ahead.

Forget the due diligence and the EGM, that's just process.

Obviously the development of the technology achieving regulatory approvals is going to be expensive and chew up $m's with development not expected for 3 years.

To date we have no details at all apart from the concept as per the website.

We take over the development and manufacture of a stent. An area we have absolutely no expertise.

Why not do a consultation deal to provide the MRI technology. Leave them to the development of the stent and obtain regulatory approvals.
The risk factor for RHT trying to take on a manufacturing & developing responsibility with a newly created stent that requires intricate surgery to place inside the human body is beyond my comprehension.

A small developing company such as RHT, needs to stick with its core business, get it bedded down and producing revenue.

It would seem the CR will have a shortfall.

If that be the case we will now have limited funds to market and promote the existing roll out for the RHT technology due for release to the market.

The revenue stream will continue to increase from the existing technology and this presumably will then be used to fund the acquisition development over the next 3 years.

How the hell this will play out is beyond me.

Expand

Hoofer I agree with your concerns , I'm sure the investors posting here would have a healthy some of shares between us to vote down if this deal if turns out to be a dog with fleas burning cash, other major investors are not fools either , lets not get too stressed until we see what the real deal is?

RHT Price at posting: 4.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war